SCHEMBL8561485

SCHEMBL8561485

Cc1nc2c(c(N3CCNCC3)n1)SCCC2

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.43
ADRB1 P08588 2/20 0.43
NPY5R Q15761 1/20 0.36
HTR2C P28335 3/20 0.36
PDE10A Q9Y233 1/20 0.36
HTR2A P28223 1/20 0.35
HRH1 P35367 1/20 0.34
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
PRKCI P41743 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9383812 0.99 GUSB (0.42) GUSBADRB1NPY5RHTR2CPDE10A
Hydrochloric Acid SCHEMBL10572665 0.85 MEN1 (0.42) NPY5RPDE10ASMN1; SMN2MAPK1HSD17B10
SCHEMBL9483593 0.84 MEN1 (0.45) HTR2ASMN1; SMN2HRH4MAPK1HSD17B10
SCHEMBL9381297 0.83 CHRM3 (0.35) GUSBADRB1NPY5RHTR2CPDE10A
SCHEMBL11107930 0.83 TLR9 (0.41) GUSBADRB1NPY5RHTR2CPDE10A
SCHEMBL8563117 0.83 HRH4 (0.42) ADRB1HTR2CHTR2AHRH1HRH4
SCHEMBL9382754 0.82 HTR2C (0.35) GUSBADRB1NPY5RHTR2CPDE10A
SCHEMBL11101741 0.82 HTR2C (0.34) GUSBADRB1NPY5RHTR2CPDE10A
Hydrochloric Acid SCHEMBL9387840 0.82 CHRM3 (0.34) GUSBADRB1NPY5RHTR2CPDE10A
SCHEMBL11104195 0.82 HRH1 (0.51) HTR2CHTR2AHRH1USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0276057-B1 Piperazinylpyrimidines as beta-adrenergic receptor blocking agents MERCK & CO INC (US) 1994-03-09 EP claimed
US-4889856-A INTRAOCULAR PRESSURE REDUCTION; CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1989-12-26 US claimed
EP-0276057-A2 Piperazinylpyrimidines as beta-adrenergic receptor blocking agents MERCK & CO. INC. (US) 1988-07-27 EP claimed
WO-1998025617-A1 SUBSTITUTED ARYL PIPERAZINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
EP-0783498-A4 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO INC (US) 1998-04-15 EP disclosed
EP-0783498-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1997-07-16 EP disclosed
US-5607936-A USEFUL IN TREATMENT OF RESPIRATORY DISEASES MERCK & CO., INC. (US) 1997-03-04 US disclosed
WO-1996010568-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1996-04-11 WO disclosed